Espicom Business Intelligence Ltd, Dec 2009, Pages: 318
to invest in their development, there is enormous potential in this high-value market.
Some of the most promising genericdrugopportunities due to come off patent in the next few years are injectable
Avalon Global Research, Oct 2010, Pages: 20
and strategies. Extensive triangulation has been done to categorize and estimate the injectables market data.
In this report, we have focused on the bright prospects of $17.5 bn genericinjectables sub segment
Greystone Associates, April 2011
unique opportunities for developers of injectabledrugs. Prefilled cartridges offer several advantages over traditional packaging in vials. For single dose devices, prefilled cartridges contain the exact
Espicom Business Intelligence Ltd, Oct 2011, Pages: 108
market analysis experience. Her recent studies include:
- Hospital InjectableDrugs: Future Prospects for Generics and Biosimilars
- Emerging Opportunities in Inhalation and Nasal Spray GenericDrugs
Espicom Business Intelligence Ltd, March 2010, Pages: 128
over 14 years pharmaceutical and healthcare market analysis experience. Among her reports are the first edition of this report, plus
InjectableGenericDrugs: Prospects and Opportunities to 2014
Global Industry Analysts, Inc., July 2009, Pages: 1810
for Ran®- Lisinopril
Oral Tablets II-158
Sandoz Releases Generic Form of Delestrogen® Injections II-158
Sanofi and UCB Roll Out XYZAL® in US II-158
Sandoz Expands Range of Generic Augmentin® Drugs II-159
Spectra Intelligence, May 2011, Pages: 67
contraceptives and infertility drugs
- How will newcomers affect the product positioning of market leaders
- What are niche market opportunities in reproductive medicine
- What the future outlook holds
Bizacumen Inc., Nov 2009, Pages: 191
injectables, dominating the market, there exist enormous opportunities and interest in developing advanced, patient friendly anticoagulants. Favorable demographic patterns, like the rapidly aging world
Espicom Business Intelligence Ltd, April 2011, Pages: 118
Drugs: Prospects and Opportunities, - Emerging Opportunities in Inhalation and Nasal Spray GenericDrugs - Multiple Sclerosis: what the future holds - The Indian Pharmaceutical Industry FOREWORD
Datamonitor, Oct 2011, Pages: 193
and pipeline drugs’ clinical and commercial attractiveness.
- Assessment of the strengths, weaknesses, opportunities and threats for marketed and late-stage pipeline candidates
- Analysis of the product
PharmaVision, March 2009, Pages: 147
on the market.
The biopharm field represents a major opportunity for generic manufacturers with sufficient resources to withstand the relatively high development costs and the technological demand. It is estimated
Datamonitor, Feb 2011, Pages: 149
, there is a lack of late-stage candidates for Gram-negative pathogens. Datamonitor believes that the launch of nine new drugs during the forecasted period (2010–19) will inject $1.98bn into the antibacterial
Espicom Business Intelligence Ltd, May 2009, Pages: 250
Holmes. Karen has over 12 years pharmaceutical and healthcare market analysis experience. Her recent studies include InjectableGenericDrugs: Prospects and Opportunities, Emerging Opportunities
Frost & Sullivan, Nov 2009, Pages: 26
reimbursement because of the availability of low-cost generics. "While drugs, especially generics, targeted toward the same therapeutic area may be less effective or more toxic, their relatively low cost
Bizacumen Inc., Nov 2009, Pages: 486
3
Patent Expiries of Branded Drugs to Trigger Generic Competition 4
New Cancer Therapies Appear Over the Horizon 4
New Generation Cancer Drugs
Espicom Business Intelligence Ltd, Sep 2008, Pages: 210
prescribe generics in order to save money, either from their own drug bill or that of the patient. It is not clear whether biosimilars will offer enough of a saving in this regard.
Will patients accept
Arrowhead Publishers, Oct 2010, Pages: 385
driving R&D and 10% of the global population regularly taking analgesia; the pain therapeutics market offers numerous lucrative commercial opportunities.
This in-depth report...
- Analyzes seven major
